171 related articles for article (PubMed ID: 32976349)
1. Clinicoepidemiologic Profile and Outcome Predicted by Minimal Residual Disease in Children With Mixed-phenotype Acute Leukemia Treated on a Modified MCP-841 Protocol at a Tertiary Cancer Institute in India.
Myint HH; Tandon S; Narula G; Prasad M; Subramanian P; Patkar N; Tembhare P; Gujral S; Banavali S
J Pediatr Hematol Oncol; 2020 Oct; 42(7):415-419. PubMed ID: 32976349
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of pediatric mixed phenotype acute leukemia treated with lymphoid directed therapy: Analysis of an institutional series from India.
Seetharam S; Thankamony P; Gopakumar KG; Nair RA; Jacob PM; Jagathnath Krishna KM; Rajeswari B; Nair M; Guruprasad CS; Prasanth VR
Pediatr Hematol Oncol; 2021 May; 38(4):358-366. PubMed ID: 33635170
[TBL] [Abstract][Full Text] [Related]
3. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
4. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D
Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434
[TBL] [Abstract][Full Text] [Related]
5. Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients.
Rasekh EO; Osman R; Ibraheem D; Madney Y; Radwan E; Gameel A; Abdelhafiz A; Kamel A; Elfishawi S
Ann Hematol; 2021 Mar; 100(3):699-707. PubMed ID: 33230570
[TBL] [Abstract][Full Text] [Related]
6. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
7. Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia.
Atchley E; Weis TM; Derkach A; Galera PK; Xiao W; Glass J; DeWolf S; Roshal M; Shah R; Stump SE
Leuk Res; 2023 Jul; 130():107311. PubMed ID: 37182399
[TBL] [Abstract][Full Text] [Related]
8. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.
Mejstrikova E; Volejnikova J; Fronkova E; Zdrahalova K; Kalina T; Sterba J; Jabali Y; Mihal V; Blazek B; Cerna Z; Prochazkova D; Hak J; Zemanova Z; Jarosova M; Oltova A; Sedlacek P; Schwarz J; Zuna J; Trka J; Stary J; Hrusak O
Haematologica; 2010 Jun; 95(6):928-35. PubMed ID: 20145275
[TBL] [Abstract][Full Text] [Related]
10. Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study.
Oberley MJ; Raikar SS; Wertheim GB; Malvar J; Sposto R; Rabin KR; Punia JN; Seif AE; Cahen VC; Schore RJ; Luca DC; Guinipero T; Woods WG; O'Gorman MRG; Orgel E
Leukemia; 2020 Jul; 34(7):1741-1750. PubMed ID: 32060402
[TBL] [Abstract][Full Text] [Related]
11. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
Hongo T; Yajima S; Sakurai M; Horikoshi Y; Hanada R
Blood; 1997 Apr; 89(8):2959-65. PubMed ID: 9108416
[TBL] [Abstract][Full Text] [Related]
12. [Long-term outcome of childhood T-cell acute lymphoblastic leukemia treated with modified national protocol of childhood leukemia in China-acute lymphoblastic leukemia 2008].
Liao C; Shen DY; Xu XJ; Xu WQ; Zhang JY; Song H; Yang SL; Zhao FY; Shen HP; Tang YM
Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):758-763. PubMed ID: 32872717
[No Abstract] [Full Text] [Related]
13. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol.
Bajel A; George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
Pediatr Blood Cancer; 2008 Nov; 51(5):621-5. PubMed ID: 18688848
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a bortezomib and reduced-intensity cytarabine-based protocol, TMC ALLR1, for relapsed childhood ALL in India.
Roy P; Islam R; Saha D; Gogoi M; Kumar Mishra D; Arora N; Parihar M; Krishnan S; Saha V
Br J Haematol; 2019 Sep; 186(6):861-865. PubMed ID: 31168836
[TBL] [Abstract][Full Text] [Related]
15. Acute lymphoblastic leukemia in a developing country: preliminary results of a nonrandomized clinical trial in El Salvador.
Bonilla M; Moreno N; Marina N; deReyes G; Shurtleff SA; Downing JR; Behm FG; Harrison PL; Ribeiro RC; Peña O; Crist WM; Antillon FG
J Pediatr Hematol Oncol; 2000; 22(6):495-501. PubMed ID: 11132215
[TBL] [Abstract][Full Text] [Related]
16. Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China.
Wei W; Chen X; Zou Y; Chang L; An W; Wan Y; Liu T; Yang W; Chen Y; Guo Y; Zhu X
BMC Pediatr; 2015 Jul; 15():80. PubMed ID: 26174476
[TBL] [Abstract][Full Text] [Related]
17. [Clinical Characteristics of Patients with Ph
Jia YN; Li Y; Gong XY; Liu KQ; Ye L; Wang HJ; Li QH; Li CW; Wang Y; Wang JX; Mi YC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):354-359. PubMed ID: 30998137
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic aberration in mixed-phenotype acute leukemia in children: A single-center retrospective review.
Chang TY; Chen SH; Jaing TH; Yang SH; Wen YC; Yang CP; Hung IJ
Pediatr Neonatol; 2021 Jan; 62(1):21-25. PubMed ID: 32859541
[TBL] [Abstract][Full Text] [Related]
19. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I
Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714
[TBL] [Abstract][Full Text] [Related]
20. Prognostic variables and survival in pediatric acute lymphoblastic leukemias: cancer institute experience.
Shanta V; Maitreyan V; Sagar TG; Gajalakshmi CK; Rajalekshmy KR
Pediatr Hematol Oncol; 1996; 13(3):205-16. PubMed ID: 8735336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]